CA1336821C - Nucleosides pour usage therapeutique - Google Patents

Nucleosides pour usage therapeutique

Info

Publication number
CA1336821C
CA1336821C CA000616870A CA616870A CA1336821C CA 1336821 C CA1336821 C CA 1336821C CA 000616870 A CA000616870 A CA 000616870A CA 616870 A CA616870 A CA 616870A CA 1336821 C CA1336821 C CA 1336821C
Authority
CA
Canada
Prior art keywords
formulation according
uracil
unit dosage
fluoro
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000616870A
Other languages
English (en)
Inventor
Charlene Louise Burns
George Walter Koszalka
Susan Mary Daluge
Joel Van Tuttle
Thomas Anthony Krenitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878726136A external-priority patent/GB8726136D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1336821C publication Critical patent/CA1336821C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000616870A 1987-11-07 1994-05-31 Nucleosides pour usage therapeutique Expired - Fee Related CA1336821C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878726136A GB8726136D0 (en) 1987-11-07 1987-11-07 Therapeutic nucleosides
GB8726136 1987-11-07
CA000582322A CA1333391C (fr) 1987-11-07 1988-11-04 Nucleosides therapeutiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000582322A Division CA1333391C (fr) 1987-11-07 1988-11-04 Nucleosides therapeutiques

Publications (1)

Publication Number Publication Date
CA1336821C true CA1336821C (fr) 1995-08-29

Family

ID=25672223

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000616870A Expired - Fee Related CA1336821C (fr) 1987-11-07 1994-05-31 Nucleosides pour usage therapeutique

Country Status (1)

Country Link
CA (1) CA1336821C (fr)

Similar Documents

Publication Publication Date Title
AU668860B2 (en) Antiviral nucleoside combination
EP0206497B1 (fr) Nucléosides thérapeutiques et leur préparation
IE56503B1 (en) Antiviral nucleosides
US5071983A (en) Therapeutic nucleosides
EP0317128B1 (fr) Pyrimidine Nucléosides Anti-HIV
US5157114A (en) 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
EP0625158B1 (fr) Nucleosides therapeutiques de la serie 2',3'-dideoxy-3'-fluoro-purine
CA1336821C (fr) Nucleosides pour usage therapeutique
EP0306597A2 (fr) Nucléosides antiviraux
US5198539A (en) 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
WO1988009332A1 (fr) Nucleosides a usage therapeutique
EP0366287A1 (fr) Nucléosides thérapeutiques
CA1327005C (fr) Nucleosides therapeutiques
EP0294113A1 (fr) Nucléosides thérapeutiques
CA1340519C (fr) Nucleosides antiviraux
NZ224007A (en) 3'-azido-3'-deoxythymidine derivatives as antiviral agents

Legal Events

Date Code Title Description
MKLA Lapsed